News and Insights

Get the latest CathWorks news, press releases, industry insights, and useful information for physicians, patients, and media.

Insights

Lenox Hill Hospital First in US to Perform 1,000 FFRangio Cases

June 11, 2025

CathWorks is proud to recognize Lenox Hill Hospital and the Northwell Health team for becoming the first institution in the United States…

Insights

The New Global Era of Patient Care with CathWorks FFRangio

May 28, 2025

CathWorks Symposium at EuroPCR 2025 – The new global era of patient care EuroPCR 2025, Paris, France – Hear from world-renowned faculty,…

Press Releases

PROVISION Study Which Met Its Primary Endpoint Now Demonstrates Similar Clinical Outcomes for FFRangio and FFR

May 22, 2025

PROVISION Study, Prospective Randomized Trial Evaluating Clinical Outcomes of FFRangio Versus FFR Guidance, Demonstrates Similar MACE Rates at One Year Paris, France…

Press Releases

CathWorks Announces Key Events for EuroPCR 2025

May 16, 2025

CathWorks announced today the schedule of key events for the company during the upcoming EuroPCR 2025 conference taking place May 20 to…

Press Releases

CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

January 2, 2025

CathWorks announced today the successful completion of enrollment of the Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment (ALL-RISE) randomized controlled…

Insights

CathWorks FFRangio: Coronary Physiology Redefined
(TCT 2024, Washington, DC)

December 3, 2024

CathWorks Symposium at TCT 2024 – Coronary Physiology Redefined Hear from world-renowned faculty, including Dr. Allen Jeremias, Dr. William F. Fearon, Dr.…

Press Releases

PROVISION Study, First Ever Prospective RCT of CathWorks FFRangio Outcomes Compared to Invasive Wire-based Physiology in Japan, Meets its Primary Endpoint

October 27, 2024

Today at the Cardiovascular Research Foundation’s annual Transcatheter Cardiovascular Therapeutics (TCT) conference taking place at the Walter E. Washington Convention Center in…

Press Releases

CathWorks Announces Key Events for TCT 2024

October 25, 2024

CathWorks, a global leader in digital health innovations, announced today the schedule of key events for the company during the upcoming Cardiovascular…

Insights

EuroPCR 2024 – FFRangio Continued to Generate Immense Buzz

May 24, 2024

The FFRangio System generated a lot of interest and excitement from keen physicians throughout the four-day EuroPCR conference in Paris, where the…

Press Releases

CathWorks Announces EU MDR Approval, Prominent Presence at EuroPCR and Full Launch of Co-promotion

May 13, 2024

CathWorks announced today that the CathWorks FFRangio® System is now approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred…

Insights

TCT 2023 Highlights: CathWorks Leaves its Mark

October 29, 2023

The CathWorks FFRangio® System generated a lot of interest and excitement from interventional cardiologists at the annual TCT conference in San Francisco.…

Insights

CathWorks FFRangio® System: Optimizing Clinical Decision Making Beyond the Numbers
(TCT 2023, San Francisco)

October 29, 2023

CathWorks Hosts Symposium Chaired by Dr. Martin B. Leon At TCT 2023, a world-renowned panel including Dr. Martin B. Leon (Chair), Dr. William Fearon, Dr. Allen Jeremias and Dr. Ajay J. Kirtane shared their experience with the…

News and Insights

Lenox Hill Hospital First in US to Perform 1,000 FFRangio Cases

The New Global Era of Patient Care with CathWorks FFRangio

PROVISION Study Which Met Its Primary Endpoint Now Demonstrates Similar Clinical Outcomes for FFRangio and FFR

CathWorks Announces Key Events for EuroPCR 2025

CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

CathWorks FFRangio: Coronary Physiology Redefined
(TCT 2024, Washington, DC)

PROVISION Study, First Ever Prospective RCT of CathWorks FFRangio Outcomes Compared to Invasive Wire-based Physiology in Japan, Meets its Primary Endpoint

CathWorks Announces Key Events for TCT 2024

EuroPCR 2024 – FFRangio Continued to Generate Immense Buzz

CathWorks Announces EU MDR Approval, Prominent Presence at EuroPCR and Full Launch of Co-promotion

TCT 2023 Highlights: CathWorks Leaves its Mark

CathWorks FFRangio® System: Optimizing Clinical Decision Making Beyond the Numbers
(TCT 2023, San Francisco)

Regulatory Status

Contact CathWorks Today